Randomized, double-blind, parallel group, placebo-controlled multi-center study evaluating the efficacy of PN 400 [esomeprazole/naproxen] BID and celecoxib QD in patients with osteoarthritis of the knee.

Trial Profile

Randomized, double-blind, parallel group, placebo-controlled multi-center study evaluating the efficacy of PN 400 [esomeprazole/naproxen] BID and celecoxib QD in patients with osteoarthritis of the knee.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Nov 2014

At a glance

  • Drugs Celecoxib; Esomeprazole/naproxen
  • Indications Musculoskeletal pain; NSAID-induced gastrointestinal damage; Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors POZEN
  • Most Recent Events

    • 05 Dec 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 28 Apr 2011 Results published in the Current Medical Research and Opinion.
    • 26 Feb 2009 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top